Table 1. Prognostic factor analysis of 2192 women with breast cancer, ORCC, 1994–1997.
|
Univariate analysis |
Multivariate analysisa |
Univariate analysis |
Multivariate analysisa |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Variables | RER (95% CI) | P-valueb | RER (95% CI) | P-valueb | Variables | RER (95% CI) | P-valueb | RER (95% CI) | P-valueb |
| Stage | 0.00000 | 0.00000 | Age (years) | 0.00005 | 0.00004 | ||||
| Stage I | 1.00 | 1.00 | 0–39 | 1.00 | 1.00 | ||||
| Stage II | 4.54 (2.32,8.89) | 3.05 (1.55,5.99) | 40–49 | 0.45 (0.29,0.68) | 0.46 (0.30,0.71) | ||||
| Stage III | 15.64 (7.78,31.44) | 8.28 (4.08,16.83) | 50–69 | 0.29 (0.19,0.44) | 0.45 (0.31,0.69) | ||||
| Stage IV | 52.35 (26.74,82.47) | 25.80 (12.88,51.65) | 70+ | 0.47 (0.29,0.75) | 0.85 (0.55,1.31) | ||||
| Treatment | 0.00000 | 0.00592 | Histology | 0.00257 | 0.08866 | ||||
| Chemotherapy | 1.00 | 1.00 | Ductal carcinoma | 1.00 | 1.00 | ||||
| Radiotherapy | 0.15 (0.06,0.40) | 0.97 (0.42,2.23) | Lobular carcinoma | 0.50 (0.24,1.01) | 0.66 (0.37,1.16) | ||||
| Surgery | 0.12 (0.06,0.25) | 0.47 (0.24,0.94) | Others | 1.76 (1.16,2.66) | 1.18 (0.80,1.74) | ||||
| C+Rc | 0.74 (0.44,1.27) | 1.07 (0.63,1.81) | Grade | 0.00000 | 0.00007 | ||||
| S+Cc | 0.25 (0.18,0.36) | 0.58 (0.39,0.86) | Grade 1 | 1.00 | 1.00 | ||||
| S+Rc | 0.02 (0.01,0.12) | 0.35 (0.15,0.81) | Grade 2 | 7.26 (1.77,29.72) | 2.68 (1.00,7.15) | ||||
| S+C+Rc | 0.19 (0.11,0.30) | 0.53 (0.33,0.85) | Grade 3 | 18.37 (4.55,74.16) | 4.87 (1.84,12.87) | ||||
Relative survival rate (RER) estimated according to regression models based on relative survival.
a
Adjusted for all the other variables in the table.
b
P-value from likelihood ratio test.
c
C=chemotherapy; R=radiotherapy; S=surgery.